HK CEO & Director Dealings (26 Jan 2024): Sun Hung Kai, Wuxi Bio, Sichuan Kelun-Bio, Wisdom Sports
The data in this insight is collated from the "shareholding disclosure" link on the HKEx website. These insights also flag those companies where...
712 Views
Remegen (9995.HK/688331.CH) - The Real Reasons for the Stock Price Collapse and the Future Prospects
RemeGen's 23Q4 results will miss expectation, leading to poor performance for 2023.The pain point isn't cashflow shortage but weak...
550 Views
China Healthcare Weekly (Sep.22) - Medical Device VBP, Restore Optimism on Healthcare, Biokin Pharma
National VBP of intraocular lens/sports medicine medical consumables begins.Investors will maintain optimism when understand the logic behind...
795 Views